Institutional Ownership
Celldex Therapeutics Inc New
CUSIP 15117B202COM NEWCLDXQ1 2026
Institutional Holders
221
13F filers
Shares Held
68.47M
Aggregate institutional
Institutional Value
$2.09B
Q1 2026
Net New Holders
+39
53 new · 14 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions53
Increased68
Decreased58
Sold out14
Institutional Holders
221 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Wellington Management Group LLP | 8.56M | $271.54M | +480.9K | Added |
| 2 | Kynam Capital Management, LP | 5.84M | $185.26M | −102.6K | Reduced |
| 3 | Blackrock, Inc. | 5.37M | $170.33M | −81.9K | Reduced |
| 4 | Fmr LLC | 3.75M | $118.92M | −1.16M | Reduced |
| 5 | Point72 Asset Management, L.P. | 3.23M | $102.45M | +1.47M | Added |
| 6 | State Street Corp | 2.80M | $88.95M | −593.5K | Reduced |
| 7 | Commodore Capital LP | 2.70M | $85.54M | +131.6K | Added |
| 8 | Eversept Partners, LP | 1.79M | $56.72M | +353.3K | Added |
| 9 | Geode Capital Management, LLC | 1.69M | $53.56M | +60.5K | Added |
| 10 | Braidwell LP | 1.36M | $43.01M | −502.0K | Reduced |
211 more institutional holders on Premium
See every fund holding Celldex Therapeutics Inc New, with full quarter-over-quarter share changes.
Unlock all holders